Agios Pharmaceuticals (AGIO) Free Cash Flow: 2012-2025
Historic Free Cash Flow for Agios Pharmaceuticals (AGIO) over the last 13 years, with Sep 2025 value amounting to -$89.7 million.
- Agios Pharmaceuticals' Free Cash Flow fell 5.99% to -$89.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$414.1 million, marking a year-over-year decrease of 25.44%. This contributed to the annual value of -$391.5 million for FY2024, which is 31.80% down from last year.
- Per Agios Pharmaceuticals' latest filing, its Free Cash Flow stood at -$89.7 million for Q3 2025, which was down 15.01% from -$78.0 million recorded in Q2 2025.
- In the past 5 years, Agios Pharmaceuticals' Free Cash Flow registered a high of -$62.0 million during Q3 2023, and its lowest value of -$134.1 million during Q4 2024.
- For the 3-year period, Agios Pharmaceuticals' Free Cash Flow averaged around -$88.0 million, with its median value being -$84.6 million (2024).
- Its Free Cash Flow has fluctuated over the past 5 years, first skyrocketed by 35.21% in 2022, then slumped by 84.45% in 2024.
- Over the past 5 years, Agios Pharmaceuticals' Free Cash Flow (Quarterly) stood at -$88.6 million in 2021, then climbed by 25.19% to -$66.3 million in 2022, then dropped by 9.73% to -$72.7 million in 2023, then plummeted by 84.45% to -$134.1 million in 2024, then decreased by 5.99% to -$89.7 million in 2025.
- Its Free Cash Flow stands at -$89.7 million for Q3 2025, versus -$78.0 million for Q2 2025 and -$112.3 million for Q1 2025.